Circle8 Group (CIRC) vs Harvard Bioscience (HBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Harvard Bioscience (HBIO) has outperformed Circle8 Group (CIRC) over the past year, gaining 93.2% versus a loss of 84.7%. Over five years, HBIO leads with a -87.6% price change compared with -99.7% for CIRC. Circle8 Group is the larger company by market cap ($52.6 million vs $38.7 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CIRC | HBIO |
|---|---|---|
| Share price | $0.46 | $8.50 |
| Market cap | $52.63M | $38.69M |
| 1-day change | -7.26% | -0.70% |
| YTD return | -65.41% | +26.87% |
| 1-year return | -84.67% | +93.18% |
| 5-year return | -99.67% | -87.57% |
| Forward P/E | — | 13.18 |
| EPS (TTM) | $-2.14 | $-2.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.56 | $9.40 |
| 52-week low | $0.313 | $3.80 |
| Distance from 52-week high | -89.91% | -9.57% |
| Average volume | 2.78M | 18.02K |
| Shares outstanding | 114.41M | 4.55M |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HBIO has outperformed CIRC by 177.8 percentage points over the past year.
CIRC vs HBIO FAQ
Which is bigger, Circle8 Group or Harvard Bioscience?
Circle8 Group (CIRC) is larger, with a market capitalization of $52.63M compared with $38.69M for Harvard Bioscience (HBIO).
Which stock has performed better over the past year, CIRC or HBIO?
HBIO returned +93.18% over the past 12 months, compared with -84.67% for CIRC (price return, excluding dividends). Past performance does not predict future results.
Are Circle8 Group and Harvard Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.